Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases. We are the only company advancing programs with both AAV and lentivirus vectors.
| Website | http://www.spirovant.com |
| Employees | 14 (9 on RocketReach) |
| Founded | 2016 |
| Address | 3675 Market St Suite 900, Philadelphia, Pennsylvania 19104, US |
| Phone | +1 267-244-8206 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Delivery, Healthcare |
| Keywords | Gene Therapy, Cystic Fibrosis Treatment, Aav Gene Therapy, Respiratory Disease Treatment, Genetic Disease Treatment, Lung Disease Treatment, Respiratory Therapeutics, Cf Treatment, Gene Therapy Development |
| Competitors | Vertex Pharmaceuticals, Incyte, Sarepta Therapeutics, Inc., Sutro Biopharma, Inc., bluebird bio, Moderna Therapeutics, CureVac, AstraZeneca, Gilead Sciences, BioMarin Pharmaceutical Inc. +36 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Spirovant Sciences, Inc. employee's phone or email?
David Whitwell is the CFO of Spirovant Sciences, Inc..
9 people are employed at Spirovant Sciences, Inc..
Spirovant Sciences, Inc. is based in Philadelphia, Pennsylvania.
The NAICS codes for Spirovant Sciences, Inc. are [54, 541714, 5417, 54171, 541].
The SIC codes for Spirovant Sciences, Inc. are [87, 873].